` Comparison: 4550 vs ALGN - Alpha Spread

4550
vs
ALGN

Over the past 12 months, Nissui Pharmaceutical Co Ltd has underperformed ALGN, delivering a return of 0% compared to the ALGN's +6% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
4550
ALGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Nissui Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
ALGN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Nissui Pharmaceutical Co Ltd
TSE:4550
999 999.9999 JPY
Align Technology Inc
NASDAQ:ALGN
173.345 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
4550, ALGN

4550
ALGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Nissui Pharmaceutical Co Ltd
Revenue
Align Technology Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
4550, ALGN

4550
ALGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Nissui Pharmaceutical Co Ltd
TSE:4550
Align Technology Inc
NASDAQ:ALGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Nissui Pharmaceutical Co Ltd
31.8%
ALGN
68.3%

Operating Margin

Nissui Pharmaceutical Co Ltd
8.7%
ALGN
15.6%

Net Margin

Nissui Pharmaceutical Co Ltd
5.9%
ALGN
10.2%

FCF Margin

Nissui Pharmaceutical Co Ltd
5.3%
ALGN
12.2%

ROE

Nissui Pharmaceutical Co Ltd
4.5%
ALGN
10.4%

ROA

Nissui Pharmaceutical Co Ltd
3.9%
ALGN
6.6%

ROIC

Nissui Pharmaceutical Co Ltd
5.1%
ALGN
8.7%

ROCE

Nissui Pharmaceutical Co Ltd
6.5%
ALGN
14.8%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
4550, ALGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
4550, ALGN

Performance Gap Between 4550 and ALGN
HIDDEN
Show

Performance By Year
4550, ALGN

Loading
4550
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 4550 to other stocks
7741
Hoya Corp
Cheaper
vs Nissui Pharmaceutical Co Ltd
MDLN
Medline Inc
M
More expensive
vs Nissui Pharmaceutical Co Ltd
ALC
Alcon AG
Cheaper
vs Nissui Pharmaceutical Co Ltd
COLO B
Coloplast A/S
Cheaper
vs Nissui Pharmaceutical Co Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett